Very good news on durable IgG antibodies to #SARSCoV2 from the Iceland experience
Just published @NEJM
nejm.org/doi/full/10.10… >4 months out
Just published @NEJM
nejm.org/doi/full/10.10… >4 months out
Iceland was one of the best performing countries vs #COVID19, starting PCR screening in January, before there was even a patient diagnosed. As a result, along with tracing/isolation, they have a seroprevalence of only 0.9% (US is now >14%, estimated) and IFR 0.3%.
The editorial is rich with context
nejm.org/doi/full/10.10…
1. "Unprecedented snapshot of seroconversion rates" with various antibody isotopes, different antigens
2. 56% cases confirmed by virus (PCR) testing so 44% infections would've been missed w/o antibody
3. 2 Waves graphic
nejm.org/doi/full/10.10…
1. "Unprecedented snapshot of seroconversion rates" with various antibody isotopes, different antigens
2. 56% cases confirmed by virus (PCR) testing so 44% infections would've been missed w/o antibody
3. 2 Waves graphic
True:
"from tests on more than 30,000 people in Iceland [15% of the population], is the most extensive work yet on the immune system’s response to the virus and is good news for efforts to develop vaccines."
by @MMarchioneAP
apnews.com/bc8888eb4e70c1…
"from tests on more than 30,000 people in Iceland [15% of the population], is the most extensive work yet on the immune system’s response to the virus and is good news for efforts to develop vaccines."
by @MMarchioneAP
apnews.com/bc8888eb4e70c1…
